Conventional dendritic cells impair recovery after myocardial infarction

Jun Seong Lee, Se Jin Jeong, Sinai Kim, Lorraine Chalifour, Tae Jin Yun, Mohammad Alam Miah, Bin Li, Abdelilah Majdoubi, Antoine Sabourin, Tibor Keler, Jean V. Guimond, Elie Haddad, Eui Young Choi, Slava Epelman, Jae Hoon Choi, Jacques Thibodeau, Goo Taeg Oh, Cheolho Cheong

Research output: Contribution to journalArticlepeer-review

41 Scopus citations


Ischemic myocardial injury results in sterile cardiac inflammation that leads to tissue repair, two processes controlled by mononuclear phagocytes. Despite global burden of cardiovascular diseases, we do not understand the functional contribution to pathogenesis of specific cardiac mononuclear phagocyte lineages, in particular dendritic cells. To address this limitation, we used detailed lineage tracing and genetic studies to identify bona fide murine and human CD103+ conventional dendritic cell (cDC)1s, CD11b+ cDC2s, and plasmacytoid DCs (pDCs) in the heart of normal mice and immunocompromised NSG mice reconstituted with human CD34+ cells, respectively. After myocardial infarction (MI), the specific depletion of cDCs, but not pDCs, improved cardiac function and prevented adverse cardiac remodeling. Our results showed that fractional shortening measured after MI was not influenced by the absence of pDCs. Interestingly, however, depletion of cDCs significantly improved reduction in fractional shortening. Moreover, fibrosis and cell areas were reduced in infarcted zones. This correlated with reduced numbers of cardiac macrophages, neutrophils, and T cells, indicating a blunted inflammatory response. Accordingly, mRNA levels of proinflammatory cytokines IL-1β and IFN-γ were reduced. Collectively, our results demonstrate the unequivocal pathological role of cDCs following MI.

Original languageEnglish
Pages (from-to)1784-1798
Number of pages15
JournalJournal of Immunology
Issue number6
StatePublished - 15 Sep 2018

Bibliographical note

Funding Information:
This work was supported by grants from the Canadian Foundation for Innovation (John R. Evans Leaders Fund to C.C.) and the Canadian Institutes of Health Research (CIHR) (MOP 125933 to C.C. and J.T., MOP 136802 to J.T., and MOP 133050 to C.C.), by Canadian HIV Cure Enterprise Team Grant HIG-133050 (to C.C. and E.H.), and by a National Research Foundation of Korea grant funded by the Korean government (2012R1A3A2026454 to G.T.O.). J.S.L. was supported by the Fonds de Recherche du Québec – Nature et Technologies. J.T. holds the Saputo Research Chair. C.C. was a recipient of a CIHR New Investigator Award and held a Société

Publisher Copyright:
Copyright © 2018 by The American Association of Immunologists, Inc.


Dive into the research topics of 'Conventional dendritic cells impair recovery after myocardial infarction'. Together they form a unique fingerprint.

Cite this